ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

Pain Relievers Protect Against Breast Cancer

April 25, 2003

CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule

May 9, 1986

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994